Further, the study results suggest that CYP2C19 SSRI substrates are associated with gastrointestinal absorption ADRs: diarrhoea, hyponatraemia, and again small for dates baby as well as pain-related ADRs: chest pain, pain in extremity, and pain. Here, CYP2C19 is linked to Hyponatremia.